• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa.

作者信息

Fouad Yasser, Barakat Salma, Hashim Almoutaz, Ghazinyan Hasmik

机构信息

Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Minia University, Minia, Egypt.

National Center for Gastrointestinal and Liver Diseases, Ibn Sina Hospital, Ministry of Health, Khartoum, Sudan.

出版信息

Nat Rev Gastroenterol Hepatol. 2024 May;21(5):297-298. doi: 10.1038/s41575-024-00918-z.

DOI:10.1038/s41575-024-00918-z
PMID:38499807
Abstract
摘要

相似文献

1
Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa.迈向统一脂肪肝命名法：来自中东和北非的声音。
Nat Rev Gastroenterol Hepatol. 2024 May;21(5):297-298. doi: 10.1038/s41575-024-00918-z.
2
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa.代谢相关脂肪性肝病的命名与定义：中东和北非地区的共识
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):57-64. doi: 10.1016/S2468-1253(20)30213-2. Epub 2020 Nov 9.
3
Author Correction: Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa.作者更正：迈向统一脂肪肝命名法：来自中东和北非的声音。
Nat Rev Gastroenterol Hepatol. 2025 Feb;22(2):146. doi: 10.1038/s41575-024-01034-8.
4
Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition.中东和北非以及撒哈拉以南非洲关于继续认可MAFLD定义的联合立场声明。
J Hepatol. 2024 May;80(5):e194-e197. doi: 10.1016/j.jhep.2024.01.033. Epub 2024 Feb 10.
5
[The information from systematic radioscopy in North Africa; presentation of a standardized nomenclature of the results of these examinations].[来自北非系统放射检查的信息；这些检查结果的标准化命名法介绍]
Rev Tuberc. 1953;17(9):972-84.
6
Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.非酒精性脂肪性肝病在亚洲、中东和北非地区的负担：来自 2009-2019 年全球疾病负担的数据。
J Hepatol. 2021 Oct;75(4):795-809. doi: 10.1016/j.jhep.2021.05.022. Epub 2021 May 31.
7
The new nomenclature SLD and categories provided better classification for elderly Chinese with liver steatosis.新的命名法SLD及分类为患有肝脂肪变性的中国老年人提供了更好的分类。
Eur J Intern Med. 2024 Sep;127:149-150. doi: 10.1016/j.ejim.2024.04.023. Epub 2024 May 3.
8
Present situation of echinococcosis in the Middle East and Arabic North Africa.中东和阿拉伯北非地区棘球蚴病的现状
Parasitol Int. 2006;55 Suppl:S197-202. doi: 10.1016/j.parint.2005.11.030. Epub 2005 Dec 6.
9
Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE study.中东和北非地区成年人群中的慢性阻塞性肺疾病：BREATHE 研究的原理和设计。
Respir Med. 2012 Dec;106 Suppl 2:S3-15. doi: 10.1016/S0954-6111(12)70010-0.
10
Changing the face of stroke care in the Middle East North Africa region.改变中东和北非地区中风护理的面貌。
J Neurol Sci. 2020 May 15;412:116727. doi: 10.1016/j.jns.2020.116727. Epub 2020 Feb 7.

引用本文的文献

1
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment.代谢功能障碍相关脂肪性肝病：一种具有异质性代谢风险因素、机制和合并症且需要整体治疗的疾病。
Nat Rev Gastroenterol Hepatol. 2025 May;22(5):314-328. doi: 10.1038/s41575-025-01045-z. Epub 2025 Feb 17.
2
Envisioning how to advance the MASH field.展望如何推动 MASH 领域的发展。
Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):726-738. doi: 10.1038/s41575-024-00938-9. Epub 2024 Jun 4.
3
Does an Aspirin a Day Take the MASLD Away?

本文引用的文献

1
Reply to: " "Fatty" or "steatotic": Position statement from a linguistic perspective by the Chinese-speaking community".回复：“‘脂肪性的’还是‘脂肪变性的’：华语社群从语言学角度的立场声明”
J Hepatol. 2025 Feb;82(2):e105-e106. doi: 10.1016/j.jhep.2024.10.026. Epub 2024 Oct 23.
2
Changing from NAFLD to MASLD: The implications for health-related quality of life data.从非酒精性脂肪性肝病转变为代谢功能障碍相关脂肪性肝病：对健康相关生活质量数据的影响。
J Hepatol. 2024 Jun;80(6):e249-e251. doi: 10.1016/j.jhep.2024.02.010. Epub 2024 Feb 23.
3
Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition.
每日服用一片阿司匹林能消除代谢相关脂肪性肝病吗？
Adv Ther. 2024 Jul;41(7):2559-2575. doi: 10.1007/s12325-024-02885-y. Epub 2024 May 15.
中东和北非以及撒哈拉以南非洲关于继续认可MAFLD定义的联合立场声明。
J Hepatol. 2024 May;80(5):e194-e197. doi: 10.1016/j.jhep.2024.01.033. Epub 2024 Feb 10.
4
What the New Definition of MASLD Left Behind: Dual Etiology With Viral Hepatitis.非酒精性脂肪性肝病新定义遗漏的内容：合并病毒性肝炎的双重病因
Clin Gastroenterol Hepatol. 2024 Aug;22(8):1751-1752. doi: 10.1016/j.cgh.2023.11.026. Epub 2023 Nov 30.
5
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病医生和患者耻辱感的全球调查。
J Hepatol. 2024 Mar;80(3):419-430. doi: 10.1016/j.jhep.2023.11.004. Epub 2023 Nov 18.
6
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识：新脂肪性肝病命名。
Ann Hepatol. 2024 Jan-Feb;29(1):101133. doi: 10.1016/j.aohep.2023.101133. Epub 2023 Jun 24.
7
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病（NAFLD）和非酒精性脂肪性肝炎（NASH）的全球流行病学：系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
8
MAFLD: perceived stigma-a single-center Mexican patient survey.非酒精性脂肪性肝炎相关脂肪性肝病：感知到的耻辱感——一项单中心墨西哥患者调查
Hepatol Int. 2023 Apr;17(2):507-508. doi: 10.1007/s12072-022-10448-y. Epub 2022 Dec 6.
9
MAFLD 2022: An ELPA/ALPA/EASO-ECPO joint statement on disease stigma.2022年脂肪性肝病防治新进展：欧洲肝脏研究协会/亚太肝脏研究协会/欧洲肥胖症研究学会-欧洲临床营养与代谢学会关于疾病污名化的联合声明
J Hepatol. 2022 Dec;77(6):1717-1719. doi: 10.1016/j.jhep.2022.08.027. Epub 2022 Aug 30.
10
Advancing the global public health agenda for NAFLD: a consensus statement.推进非酒精性脂肪性肝病的全球公共卫生议程：共识声明。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.